Byung Hyun Byun Selected Research

Byung Hyun Byun Research Topics

Disease

10	Osteosarcoma (Osteogenic Sarcoma) 05/2021 - 05/2013
8	Neoplasms (Cancer) 02/2023 - 01/2013
6	Breast Neoplasms (Breast Cancer) 02/2022 - 04/2014
5	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 10/2008
5	Neoplasm Metastasis (Metastasis) 05/2021 - 07/2012
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2023 - 04/2013
3	Alzheimer Disease (Alzheimer's Disease) 04/2020 - 03/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2014 - 04/2008
2	Lymphoma (Lymphomas) 01/2023 - 12/2019
2	Disease Progression 02/2022 - 03/2014
2	Cognitive Dysfunction 04/2020 - 03/2017
2	Thyroid Neoplasms (Thyroid Cancer) 02/2019 - 01/2013
1	Infarction (Infarctions) 01/2024
1	Myocardial Infarction 01/2024
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2023
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 10/2021
1	Pain (Aches) 10/2021
1	Brain Neoplasms (Brain Tumor) 09/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Dementia (Dementias) 01/2020
1	Essential Tremor (Essential Tremors) 01/2018
1	Parkinson Disease (Parkinson's Disease) 01/2018
1	Familial primary gastric lymphoma 12/2016
1	Ewing Sarcoma (Sarcoma, Ewing) 01/2016
1	Colorectal Neoplasms (Colorectal Cancer) 12/2014
1	Pathologic Complete Response 12/2014
1	Rectal Neoplasms (Rectal Cancer) 12/2014
1	Lymphatic Metastasis 04/2014
1	Necrosis 07/2013
1	Papillary Thyroid Cancer 01/2013
1	Lung Neoplasms (Lung Cancer) 07/2012

Drug/Important Bio-Agent (IBA)

12	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2024 - 10/2008
4	Rituximab (Mabthera)FDA Link 12/2023 - 04/2013
4	131I-rituximabIBA 01/2023 - 04/2013
3	human ERBB2 proteinIBA 02/2022 - 09/2016
3	18F-FC119SIBA 04/2020 - 03/2017
3	Fluorine-18IBA 12/2016 - 08/2014
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2016 - 04/2013
3	Vincristine (Oncovin)FDA LinkGeneric 10/2016 - 04/2013
3	Prednisolone (Predate)FDA LinkGeneric 10/2016 - 04/2013
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2016 - 04/2013
2	Trastuzumab (Herceptin)FDA Link 02/2022 - 01/2021
2	AcidsIBA 02/2022 - 01/2021
2	Amyloid (Amyloid Fibrils)IBA 04/2020 - 01/2019
2	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 04/2020 - 03/2017
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 01/2016
1	alpha- Manp(1- 3)- (beta- GlcpNAc(1- 4))- (alpha- Manp(1- 6))- beta- Manp(1- 4)- beta- GlcpNAc(1- 4)- (alpha- Fucp(1- 6))- GlcpNAc (MGMM)IBA 01/2024
1	Proteins (Proteins, Gene)FDA Link 02/2023
1	RNA (Ribonucleic Acid)IBA 02/2023
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 02/2022
1	64Cu-DOTA-trastuzumabIBA 02/2022
1	Peptide Receptors (Peptide Receptor)IBA 10/2021
1	Radioisotopes (Radionuclides)IBA 10/2021
1	Tyrosine (L-Tyrosine)FDA Link 09/2021
1	Amino Acids FDA Link 09/2021
1	ezrinIBA 05/2021
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 01/2021
1	AntigensIBA 01/2021
1	LigandsIBA 01/2021
1	IodineIBA 02/2019
1	Therapeutic UsesIBA 02/2019
1	Thyroglobulin FDA Link 02/2019
1	2- carbomethoxy- 8- (3- fluoropropyl)- 3- (4- iodophenyl)tropaneIBA 01/2018
1	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 01/2018
1	Amyloid beta-PeptidesIBA 03/2017
1	Estrogen ReceptorsIBA 09/2016
1	Progesterone Receptors (Progesterone Receptor)IBA 09/2016
1	Biomarkers (Surrogate Marker)IBA 09/2016
1	Indicators and Reagents (Reagents)IBA 05/2013
1	ErbB Receptors (EGF Receptor)IBA 01/2010
1	Gefitinib (Iressa)FDA Link 04/2008

Therapy/Procedure

12	Neoadjuvant Therapy 12/2020 - 05/2013
9	Drug Therapy (Chemotherapy) 02/2022 - 04/2013
7	Radioimmunotherapy 12/2023 - 04/2013
6	Therapeutics 01/2023 - 01/2013
2	Adjuvant Chemotherapy 01/2020 - 12/2014
1	Ligation 01/2024
1	Boron Neutron Capture Therapy 10/2021
1	Brachytherapy 10/2021
1	Synovectomy 10/2021
1	Chemoradiotherapy 03/2014
1	Thyroidectomy 01/2013